Anebulo Pharmaceuticals, Inc. (ANEB) Tops Q3 EPS by 4c

Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q3 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.

You May Also Be Interested In

• Baird Starts Jersey Mike's Subs (JMKE) at Outperform
• Stifel Starts Jersey Mike's Subs (JMKE) at Buy
• JPMorgan Upgrades United Overseas Bank Ltd. (UOB:SP) (UOVEY) to Neutral